pharmaphorum

MAY 27, 2021

The way in which the industry came together to support the development of the COVID-19 vaccines has shown that it is equally important to determine how to apply the lessons of the last year to the future. The organisations that will be competitive in the drug development industry will be those that enable AI capabilities. .

Vaccines 119

Vaccines Drug Development Diabetes 119

Pharmaceutical Technology

FEBRUARY 14, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Diabetes 40

Diabetes Immunization Immunity Vaccines 40

The Digital Apothecary

MAY 13, 2017

As a pharmacy educator, I love the history of drug development for instance, and in every discussion, I have with students, whether in the classroom or small groups, I like to frame our current understanding of what we are doing based on what we used to do. Take for example Type I Diabetes (sometimes called Juvenile Diabetes).

Diabetes 130

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

pharmaphorum

NOVEMBER 2, 2020

With a collective sense of uncertainty, many are pinning their hopes on a vaccine and treatment, and sophisticated technology could help speed up the process of finding an effective medicine. This knowledge is critical in understanding how effective certain drugs might be in treating the virus. One example is Novartis.

Vaccines 132

Vaccines Drug Development Diabetes Immunization 132

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. So, living with diabetes, living with multiple sclerosis, living with ovarian cancer.” But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

European Pharmaceutical Review

JULY 20, 2022

Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Known as pharmacovigilance, our epidemiological research records and investigates adverse drug reactions when medicines are used by the general public. Journal of Diabetes and its Complications.

Adverse Reactions 97

Adverse Reactions Diabetes Hospitals Vaccines 97

PharmaShots

MAY 9, 2023

Social Factors Generation Health: This aspect is crucial as it corresponds to the layouts of drug development requirements based on the patient population of geography. Compared to the younger generation, the geriatric population requires more drugs.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

Pharmaceutical Technology

DECEMBER 22, 2022

The company is a clinical-stage biopharmaceutical startup that uses its artificial intelligence (AI)-enabled platform to measure brain biomarkers, including electroencephalogram (EEG) activity and behavioural patterns, wearable data, genetics and other factors, to drive targeted drug development in mental health.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. It has also been granted RPD and FTD designation in the US and has obtained Orphan Drug Designation in both US and Europe. Funding Value: $15.9M

Vaccines 40

Vaccines Immunization Immunity Diabetes 40

PharmaShots

APRIL 3, 2023

of the newly combined company The combined companies’ focus is to advance Elicio’s lymph node-targeting amphiphile technology to develop immunotherapies & also focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors is currently being evaluated in the P-I trial (AMPLIFY-201) for PDAC and CRC.

Biosimilars 40

Biosimilars Diabetes Compounding Hospitals 40

Pharmaceutical Technology

MARCH 2, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Chemotherapy 40

Chemotherapy Vaccines Diabetes Immunization 40

European Pharmaceutical Review

OCTOBER 3, 2024

What are the main trends or recent advances in oral small molecule drug development? Daniel Vitt (DV): A current trend in oral small molecule drug development is a shift towards creating more selective and patient-friendly drugs. GLP-1 Receptor Agonists In The Treatment Of Type 2 Diabetes – State-Of-The-Art.

Immunization 52

Immunization Immunity Drug Development Diabetes 52

pharmaphorum

SEPTEMBER 1, 2020

The first was insulin – Frederick Banting and colleagues managed to isolate insulin that could treat diabetes, up until that point a fatal condition. Meanwhile, in infectious diseases, the pharma industry has been able to produce effective drugs that could lead to the eradication of hepatitis C in the next few years.

Diabetes 145

Diabetes Immunization Immunity Vaccines 145